The University of Chicago Header Logo

Connection

Nora T. Jaskowiak to Protein Kinase Inhibitors

Back to Details
This is a "connection" page, showing publications Nora T. Jaskowiak has written about Protein Kinase Inhibitors.
Nora T. Jaskowiak
Connection Strength
0.030
Protein Kinase Inhibitors
  1. MK-2206 and Standard Neoadjuvant Chemotherapy Improves Response in Patients With Human Epidermal Growth Factor Receptor 2-Positive and/or Hormone Receptor-Negative Breast Cancers in the I-SPY 2 Trial. J Clin Oncol. 2020 04 01; 38(10):1059-1069.
    View in: PubMed
    Score: 0.030
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.